Viatris (VTRS) P/E ratio

P/E ratio · fiscal 2023
216.6×

The P/E ratio of Viatris (VTRS) was 216.6× at the end of fiscal 2023 (December 31, 2023). That is 3227.8% higher than the 6.5× of fiscal 2022. Figures as of 18 Nov 2026, 11:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio, fiscal 2023
216.6×
Change on fiscal 2022
+3227.8%
Highest on record
216.6×fiscal 2023
Lowest on record
6.5×fiscal 2022
Fiscal years on record
32018–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Viatris P/E ratio, in more detail

Across the 3 fiscal year-ends on record (2018–2023), the highest was 216.6× in fiscal 2023 and the lowest 6.5× in fiscal 2022.

History · 3 fiscal years

P/E ratio at each fiscal year-end

Viatris P/E ratio, year by year

Viatris (VTRS) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
2025——$12.45-$3.00
2024——$12.45-$0.53
2023216.6× 3,227.8% up$10.83$0.05
20226.5×—$11.13$1.71
2021——$13.53-$1.05
2020——$18.74-$1.11
2019——$20.10$0.03
201840.3×—$27.40$0.68

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Viatris and comparable companies
CompanyP/E ratio
United Therapeutics UTHR22.0×
Incyte INCY60.8×
Tenet Healthcare THC8.2×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on VTRS

Viatris, figure by figure

Viatris (VTRS) overview: price, valuation and scorecardAll health care companies by market value

Viatris P/E ratio: questions and answers

What is Viatris's P/E ratio?

The P/E ratio of Viatris (VTRS) was 216.6× at the end of fiscal 2023 (December 31, 2023). That is 3227.8% higher than the 6.5× of fiscal 2022.

What are the highest and lowest P/E ratio figures on record for Viatris?

Across the 3 fiscal year-ends on record (2018–2023), the highest was 216.6× in fiscal 2023 and the lowest 6.5× in fiscal 2022.

How is Viatris's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Viatris it is on record here for 3 fiscal years, 2018 to 2023.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Viatris (VTRS) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/VTRS/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.